Pharmaceutics (Mar 2012)

Ophthalmic Drug Delivery in Glaucoma—A Review

  • Ingrida Januleviciene,
  • Ruta Barsauskaite,
  • Lina Siaudvytyte

DOI
https://doi.org/10.3390/pharmaceutics4010243
Journal volume & issue
Vol. 4, no. 1
pp. 243 – 251

Abstract

Read online

Glaucoma is a progressive optic neuropathy and medical therapy is the initial option for the treatment of this potentially blinding condition. Topical instillation of eye drops from the bottle is the most common glaucoma drug delivery form. Due to limited permeability of anterior ocular surface, natural clearance and drainage, eye drops contain large amounts of inactive ingredients. Effective penetration enhancers are known as irritants causing ocular discomfort. Although drug efficacy is determined by active ingredients, inactive agents can affect tolerance and can result in conjunctival irritation and hyperemia and influence patients’ adherence and quality of life.

Keywords